The medical research company Seattle Genetics (1998) has in recent years expanded and achieved new heights in the medical research to fight against cancer. The founder and President and CEO of the company are Dr. Clay Siegall. He is recognized internationally for his successes. His lifelong passion to help patients with cancer is what inspired him and drove him to create Seattle Genetics.
Dr. Clay Siegall is a former student of George Washington University. He graduated with honors earing his Ph. D. in Genetics. His first job was at the Bristol – Myers Squibb Pharmaceutical Research Institute where he worked as a Senior Research Investigator. He was later promoted to Principal Scientist at the Bristol – Myers Squibb Institute for his successful research results and good leadership skills. After he had worked for some time at the at the National Cancer Institute as Staff Fellow and Biotechnology Fellow, Dr. Clay Siegall decided to found his own medical research company Seattle Genetics. The company was established in early 1998. The company excelled in the research against cancer and was responsible for the creation of the first antibody – drug conjugates (ADCs). Another medication that Seattle Genetics developed was approved by the FDA in late 2011 – ADCETRIS® (brentuximab vedotin). This medication is currently available internationally in more than sixty-five countries.
In order to supply his company with enough resource and fund further research, Dr. Clay Siegall personally raised more than 2 billion dollars for Seattle Genetics. He has a history of philanthropy and volunteer work as well. Other than the ADCs and brentuximab vedotin drug, Dr. Clay Siegall owns nearly 15 patents. In 2013 he was recognized for his medical and scientific achievements and was named Alumnus of the Year for Computer, Math and Natural Sciences by the University of Maryland. He gave a rousing speech that inspired many. Dr. Siegall has written and co-written a multitude of articles on medical and scientific topics over the years and has given seminars at different universities to help educate the future medical professionals. He has also been an avid contributor to spreading cancer awareness.